1-4 of 4
Anna Maria Frustaci
Close
Sort by
Journal Articles

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib

Silvia Bonfiglio, Lesley-Ann Sutton, Viktor Ljungström, Antonella Capasso, Tatjana Pandzic, Simone Weström, Hassan Foroughi-Asl, Aron Skaftason, Anna Gellerbring, Anna Lyander, Francesca Gandini, Gianluca Gaidano, Livio Trentin, Lisa Bonello, Gianluigi Reda, Csaba Bödör, Niki Stavroyianni, Constantine S. Tam, Roberto Marasca, Francesco Forconi, Panayiotis Panayiotidis, Ingo Ringshausen, Ozren Jaksic, Anna Maria Frustaci, Sunil Iyengar, Marta Coscia, Stephen P. Mulligan, Loïc Ysebaert, Vladimir Strugov, Carolina Pavlovsky, Renata Walewska, Anders Österborg, Diego Cortese, Pamela Ranghetti, Panagiotis Baliakas, Kostas Stamatopoulos, Lydia Scarfò, Richard Rosenquist, Paolo Ghia
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2794–2806.
https://doi.org/10.1182/bloodadvances.2022008821
Published: 2023
Includes: Supplemental data
Journal Articles

Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort

Gianluigi Reda, Veronica Mattiello, Anna Maria Frustaci, Andrea Visentin, Francesca Romana Mauro, Idanna Innocenti, Massimo Gentile, Diana Giannarelli, Alessandro Noto, Ramona Cassin, Antonino Neri, Luca Laurenti, Alessandra Tedeschi
Journal: Blood Advances
Blood Adv (2023) 7 (4): 525–528.
https://doi.org/10.1182/bloodadvances.2022007619
Published: 2023
Includes: Supplemental data
Journal Articles

Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial

Lydia Scarfò, Silvia Ferrari, Anna Maria Frustaci, Monica Tani, Alessia Bari, Eloise Scarano, Maria Colia, Pamela Ranghetti, Piera Angelillo, Paola Ronchi, Maurilio Ponzoni, Andrés J. M. Ferreri, Paolo Ghia
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5356–5359.
https://doi.org/10.1182/bloodadvances.2022007138
Published: 2022
Includes: Supplemental data
Journal Articles

Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?

Clinical Trials & Observations
Alessandra Tedeschi, Anna Maria Frustaci, Francesca Romana Mauro, Annalisa Chiarenza, Marta Coscia, Stefania Ciolli, Gianluigi Reda, Luca Laurenti, Marzia Varettoni, Roberta Murru, Claudia Baratè, Paolo Sportoletti, Antonino Greco, Chiara Borella, Valentina Rossi, Marina Deodato, Annalisa Biagi, Giulia Zamprogna, Angelo Curto Pelle, Gianfranco Lapietra, Candida Vitale, Francesca Morelli, Ramona Cassin, Alberto Fresa, Chiara Cavalloni, Massimiliano Postorino, Claudia Ielo, Roberto Cairoli, Francesco Di Raimondo, Marco Montillo, Giovanni Del Poeta
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5490–5500.
https://doi.org/10.1182/bloodadvances.2021004824
Published: 2021
Includes: Supplemental data